JENNIFER BAUER: Open Payments
NPI 1790875698 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,568 in 127 payments from 18 companies in 2025. Trend: 2023 $1,459 · 2024 $2,107 · 2025 $2,568
Food & beverage: $2,473Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $390 |
| LEO Pharma Inc. | 22 | $356 |
| ABBVIE INC. | 12 | $334 |
| GENZYME CORPORATION | 12 | $271 |
| Novartis Pharmaceuticals Corporation | 10 | $264 |
| Galderma Laboratories, L.P. | 21 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $129 |
| Amgen Inc. | 4 | $117 |
| Arcutis Biotherapeutics, Inc. | 6 | $116 |
| UCB, Inc. | 4 | $116 |
Products named: TREMFYA, ADBRY, DUPIXENT, SKYRIZI, NEMLUVIO, OTEZLA, Zoryve, Bimzelx.
Industry payments across VA — which companies pay providers there.
